Category: COVID-19

What is the “New Normal” for Medical Residents?

November 9, 2020

COVID-19 has upended virtually every aspect of healthcare, including medical education. As the novel coronavirus expanded from a crisis to a pandemic, medical students adjusted to online learning from home. Residents and fellows were told to avoid direct patient care, got pulled into ERs and ICUs to treat COVID-19 patients, or saw clinical rotations canceled altogether.

Evidence and Hope During the Pandemic

September 2, 2020

Encouraging results were published today, September 2, in JAMA reporting on the reduction in 28-day mortality associated with steroid administration in critically ill COVID-19 patients. The authors reported on their prospective meta-analysis of 7 randomized trials, with a total of 1703 patients, who were randomized to either corticosteroids or placebo (or usual care). There were

Tips to Address the Challenges of non-COVID Care in the Time of a Pandemic

August 10, 2020

In addition to managing the enormous burden of COVID-19 infection and mortality, clinicians are also charged with how we can best provide ongoing regular care for non-COVID patients.

COVID-19: Impact on Cardiovascular Disease Care, Lifelong Learning, and Research

July 27, 2020

In a special report last week, the European Heart Journal spoke to cardiovascular disease (CVD) thought leaders across the globe to gather their insights on the impact of the COVID-19 pandemic on cardiovascular care.

Virtual Care: Time to Develop Your “Screenside” Manner?

July 22, 2020

Various healthcare organizations are working to better prepare physicians and advanced practice providers for best practices in providing virtual care.

Post-COVID-19: A New and Improved Normal?

July 14, 2020

The pandemic has accelerated the pace of positive change, exposed longstanding racial inequalities that resulted in a disproportionate burden of COVID-19 infection and mortality, and demonstrated new learning needs for health care professionals. 

Dexamethasone in the Treatment of COVID-19

June 16, 2020

THE RECOVERY TRIAL News emerged from the UK on June 16 around very promising results with dexamethasone in the treatment of COVID-19 infected patients in the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial.  RECOVERY is a randomized trial investigating whether treatment with either (1)Lopinavir-Ritonavir, (2)Hydroxychloroquine, (3)Corticosteroids, (4)Azithromycin,(5) Convalescent plasma or (6)Tocilizumab prevents death in patients with COVID-19.

The Endothelium: A Common Denominator Underlying “Atypical” Manifestations of COVID-19?

June 15, 2020

A group of Italian researchers recently hypothesized that it is actually the endothelium that is being targeted by the COVID-19 virus.

Multi-System Inflammatory (Kawasaki-Like) Syndrome Associated with COVID-19

May 27, 2020

It was initially thought that perhaps children, when infected with COVID-19, developed milder cases which appear clinically like a minor upper respiratory infection. In late April, however, the first published case of a Kawasaki-like disease associated with COVID-19 was described in Hospital Pediatrics.

Remdesivir for COVID-19: A Promising Early Report

May 27, 2020

To date, several pharmaceutical agents have been evaluated in the treatment of COVID-19. On May 23, the first report of a positive response to a therapeutic agent, remdesivir, was reported in the New England Journal of Medicine. The positive top line results of this trial were shared via a press release a few weeks ago.

1 of 2